Multikinase Inhibitor Treatment in Thyroid Cancer

Thyroid cancer is the most common endocrine malignancy. Most thyroid cancer types respond well to conventional treatment consisting of surgery and radioactive iodine (RAI) therapy. Unfortunately, some thyroid cancer types are resistant to surgical and RAI therapy. Multikinase inhibitors (MKIs) can b...

Descripción completa

Detalles Bibliográficos
Autores principales: Ancker, Ole Vincent, Krüger, Marcus, Wehland, Markus, Infanger, Manfred, Grimm, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982227/
https://www.ncbi.nlm.nih.gov/pubmed/31861373
http://dx.doi.org/10.3390/ijms21010010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982227/
https://www.ncbi.nlm.nih.gov/pubmed/31861373
http://dx.doi.org/10.3390/ijms21010010

Ejemplares similares